Shares of Elevance Health, Inc. (ELV) have gained 11.8% in the year-to-date period compared with 3.4% growth of the industry it belongs to, thanks to its strong operations, new contracts in its Medicaid business and optimization efforts. Factors such as premium rate increases and inorganic growth initiatives are further enhancing its results, allowing the company to raise its guidance, which has been well-received by investors.Elevance Health, with a market capitalization of $122.6 billion, is one of the la ...